Answer to Question 1
Correct Answer: 2
Rationale 1: Symptom-targeted therapy, antidepressants, and antianxiety drugs are used to treat irritable bowel syndrome (IBS).
Rationale 2: The pharmacotherapy for inflammatory bowel disease (IBD) includes 5-aminosalicylic acid (5-ASA) agents, immunosuppressive agents, and biologic therapies.
Rationale 3: Antispasmodics and serotonin agents are used to treat irritable bowel syndrome (IBS).
Rationale 4: 5-aminosalicylic acid (5-ASA) agents are used to treat inflammatory bowel disorder (IBD). Symptom-targeted therapy and antianxiety agents are used to treat irritable bowel syndrome (IBS).
Global Rationale: The pharmacotherapy for inflammatory bowel disease (IBD) includes 5-aminosalicylic acid (5-ASA) agents, immunosuppressive agents, and biologic therapies. Symptom-targeted therapy, antidepressants, and antianxiety drugs are used to treat irritable bowel syndrome (IBS). Antispasmodics and serotonin agents are used to treat irritable bowel syndrome (IBS).
Answer to Question 2
Correct Answer: 1,4,5
Rationale 1: Aging slows fecal transit time, which may result in constipation.
Rationale 2: Infections can contribute to diarrhea.
Rationale 3: Malabsorption can contribute to diarrhea.
Rationale 4: Physical activity aids with peristalsis. A sedentary lifestyle could contribute to constipation.
Rationale 5: Decreased food intake can decrease the bulk of stool and contribute to constipation.
Global Rationale: Constipation occurs more frequently in older adults because fecal transit time through the colon slows with aging. This population also exercises less, has diminished food intake, and is more likely to take certain drugs that cause constipation at a higher rate than in younger adults. Infections and malabsorption are more likely to result in diarrhea.